latest news in companies
Investors Sue Fermi Inc. Over Alleged AI Campus Funding Fraud
San Diego, Friday, 9 January 2026.
Fermi shares plummeted 59% from their IPO price after the termination of a critical $150 million funding agreement, triggering a class action lawsuit alleging the company misled investors about AI campus demand.
Comstock Clears Final Regulatory Hurdle to Launch Industrial-Scale Solar Recycling Operations
Virginia City, Friday, 9 January 2026.
Securing its final permit today, Comstock Metals is set to commission a facility capable of recycling 3 million solar panels annually, creating a critical zero-landfill solution for the energy sector.
Atos Partners with World DanceSport Federation to Modernize Global Competitions
Paris, Friday, 9 January 2026.
Leveraging extensive major event experience, Atos joins the World DanceSport Federation to overhaul digital infrastructure, focusing on ticketing and data insights to elevate the global fan experience.
Nintendo Bolsters US Strategy with Mario Tennis Fever and Lifestyle Expansion
Redmond, Friday, 9 January 2026.
Nintendo strengthens its 2026 portfolio with Mario Tennis Fever, featuring a record 38-character roster, and the My Mario lifestyle line, strategically diversifying revenue beyond traditional software.
Dogecoin Cash Completes Historic Blockchain-Linked Security Distribution Under FINRA Oversight
New York, Friday, 9 January 2026.
Dogecoin Cash, Inc. successfully executed a blockchain-linked security distribution notified by FINRA, marking a historic integration of blockchain assets within traditional U.S. regulatory frameworks.
Alveus Therapeutics Targets Weight Loss Quality Over Quantity with $160 Million Series A
Copenhagen, Friday, 9 January 2026.
On January 8, 2026, Alveus Therapeutics signaled a strategic shift in the crowded obesity market, closing a $160 million Series A round led by New Rhein Healthcare Investors, Andera Partners, and Omega Funds. Rather than simply competing on the quantity of pounds shed, Alveus is addressing the “quality” of weight loss—specifically muscle preservation and long-term maintenance—to combat the high discontinuation rates associated with current blockbuster drugs. Capitalizing on persistent investor appetite for metabolic innovation, the funding accelerates Phase 2 development of ALV-100, a GIP receptor antagonist designed to offer durable efficacy and improved body composition where existing treatments fall short.
La Liga Escalates Piracy Dispute With Cloudflare to Protect Billion-Dollar Broadcast Rights
Madrid, Friday, 9 January 2026.
Claiming 35% of illegal streams flow through Cloudflare’s network, La Liga has escalated its battle to protect $7 billion in broadcast assets against alleged digital piracy facilitation.
Radiant Ridge Energy Links Natural Gas Supply Directly to High-Performance Computing
Calgary, Friday, 9 January 2026.
Radiant Ridge Energy is redefining energy infrastructure with a new 40MW project in Northern Alberta that directly converts natural gas into electricity for high-performance computing. This innovative “digital midstream” approach bypasses traditional grid constraints, offering a direct, reliable energy pathway specifically designed for the data-intensive digital economy.
